Publications by authors named "S P Sidorov"

Background: Lyme disease (LD) is caused by and is the most common tickborne disease in the northern hemisphere. Although classical characteristics of LD are well-known, the diagnosis and treatment are often delayed. Laboratory diagnosis by serological testing is recommended for most LD manifestations.

View Article and Find Full Text PDF

We present a series of articles proving the existence of a previously unknown mechanism of interaction between hematopoietic stem cells and extracellular double-stranded DNA (and, in particular, double-stranded DNA of the peripheral bloodstream), which explains the possibility of emergence and fixation of genetic information contained in double-stranded DNA of extracellular origin in hematopoietic stem cells. The concept of the possibility of stochastic or targeted changes in the genome of hematopoietic stem cells is formulated based on the discovery of new, previously unknown biological properties of poorly differentiated hematopoietic precursors. The main provisions of the concept are as follows.

View Article and Find Full Text PDF

Age-related inflammation or inflammaging is a key mechanism that increases disease burden and may control lifespan. How adipose tissue macrophages (ATMs) control inflammaging is not well understood in part because the molecular identities of niche-specific ATMs are incompletely known. Using intravascular labeling to exclude circulating myeloid cells and subsequent single-cell sequencing with orthogonal validation, we define the diversity and alterations in niche resident ATMs through lifespan.

View Article and Find Full Text PDF
Article Synopsis
  • * The MYTHIC Study is designed as a rigorous trial involving 13 Swiss pediatric centers, comparing macrolide treatment to placebo in children aged 3-17 diagnosed with pneumonia, using precise tests to confirm M. pneumoniae infection.
  • * The main goals are to assess the time to stabilize vital signs and determine any changes in patient care within 28 days, with an aim to show that the placebo is not significantly less effective than macrolide treatment in managing this infection.
View Article and Find Full Text PDF